Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 6.6% – What’s Next?

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) traded down 6.6% on Monday . The company traded as low as $8.26 and last traded at $8.57. 332,532 shares were traded during trading, a decline of 76% from the average session volume of 1,358,660 shares. The stock had previously closed at $9.17.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of Tonix Pharmaceuticals in a report on Monday, February 10th. They set a “sell” rating for the company.

Tonix Pharmaceuticals Price Performance

The company has a 50 day moving average price of $26.53 and a 200-day moving average price of $22.56. The company has a quick ratio of 2.81, a current ratio of 3.33 and a debt-to-equity ratio of 0.07. The company has a market cap of $15.76 million, a price-to-earnings ratio of 0.00 and a beta of 2.07.

Hedge Funds Weigh In On Tonix Pharmaceuticals

Several large investors have recently modified their holdings of the business. Commonwealth Equity Services LLC bought a new stake in shares of Tonix Pharmaceuticals in the fourth quarter worth $40,000. Two Sigma Investments LP acquired a new position in Tonix Pharmaceuticals during the 4th quarter worth about $66,000. PFG Investments LLC bought a new stake in shares of Tonix Pharmaceuticals in the 4th quarter valued at about $72,000. Northern Trust Corp acquired a new stake in shares of Tonix Pharmaceuticals in the fourth quarter valued at about $162,000. Finally, Point72 Asset Management L.P. bought a new position in shares of Tonix Pharmaceuticals during the fourth quarter worth about $526,000. Institutional investors own 82.26% of the company’s stock.

About Tonix Pharmaceuticals

Tonix Pharmaceuticals Holding Corp., a biopharmaceutical company, focuses on developing, discovering, commercializing, and licensing therapeutics to treat and prevent human disease and alleviate suffering. It markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.